Strong pivot to cancer and Alzheimer’s bearing fruit alongside the traditional core

Sector: Pharmaceuticals

  • World’s 15th largest pharmaceutical firm
  • Active in human and animal health
  • Favoured partnerships over big acquisitions
  • Strong strategic portfolio shifts
  • Pipeline in cancer, diabetes and Alzheimer’s
  • Launch of Basaglar and Lartruvo

$5.2bn R&D Investment

44 US Patents

8.9% Revenue Growth from New Products

Read more